Outcome of Board Meeting

Date: 04.11.2026 To, To, BSE Limited National Stock Exchange of India Listing Department Limited Phiroze Jeejeebhoy Towers, Listing Department “Exchange Plaza,” 25th Floor, Dalal Street, C-1, Block G, Bandra – Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 544666 Scrip Code: GKSL Dear Sir Sub: Outcome of the Board meeting 1) Financial results – Attached as Annexure I Pursuant to Regulation 30 and 33(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors at its Meeting held today i.e. November 04, 2026 based on recommendations of Audit Committee, inter-alia, considered and approved the following: a) Unaudited standalone and consolidated financial results for the quarter ended on September 30, 2026. b) Limited Review Report of the Statutory Auditors of the Company, M/s. Y M Shah & Co., Vadodara, on the above Un-audited Financial Results, (Standalone and Consolidated). Integrated filling (Financials) pursuant to the SEBI circular no SEBI/HO/CFD/CFD- PoD-2/CIR/P/2024/185 dated December 31, 2024, is being done separately in XBRL format in accordance with relevant circulars issued by the stock exchanges. Further, pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Chapter III, Section III-A, clause (D), sub-clause 19 of the SEBI master circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, we declare and confirm that the auditor’s reports on standalone financial results and consolidated financial results are unmodified. The meeting of the Board commenced on 4.45 p.m. and concluded at 6 p.m. Please acknowledge the receipt and inform the members of the exchange. Yours faithfully For Gujarat Kidney And Superspeciality Limited Pragnesh Bharpoda Managing Director (DIN: 01033141)